Anti-CD20 Monoclonal Antibodies (mABs) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Anti-CD20 Monoclonal Antibodies (mABs) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : September, 2020 | Pharmaceutical | PPT format

Report Digest


Global Anti-CD20 Monoclonal Antibodies (mABs) Market: Overview 

There are various drugs available in the market for the treatment of diseases like cancer, autoimmune disorders, and various other neurological disorders. However, majority of these drugs have side-effects associated with them which are resulting low patient adherence. Owing to these side-effects and various research and developments in the field of targeted therapies, like anti-CD20 mABs, have increased over the period of time. As a result of these R&D, these new drugs have significantly low side-effects. This is the prime reason that is fueling the growth of global anti-CD20 monoclonal antibodies market during the forecast of 2018 to 2028. 

A report by TMR Research provides valuable insights on global anti-CD20 monoclonal antibodies market for the readers. The insights can help the readers to understand the dynamics of market which can be beneficial for them to have a sustainable future in global anti-CD20 monoclonal antibodies market. 

Global Anti-CD20 Monoclonal Antibodies (mABs) Market: Notable Developments 

Since the market is quite niche, various players are heavily applying for the approval to Food and Drugs Administration or FDA. These approvals are mandatory for the players to use their drugs commercially. Also these players are also investing in research and development departments to develop drugs that have less side-effects on the patients. These strategies by the players are their resort to withstand the competition of global anti-CD20 monoclonal antibodies market. 

Some of the instances of players adopting strategies for a successful future in market are mentioned below: 

  • In June 2019, Roche Holding AG gained the FDA approval for its polatuzumab vedotin-piiq drug Poilvy. The drug is aimed to treat lymphoma and has 25% less side effects than those from traditional drugs that are available in the market. AS a result of this approval the company can commercialize its drug and acquire major share of global anti-CD20 monoclonal antibodies market. 
  • In August 2019, Amgen acquired Otezla and gained the access to the company’s technology to enhance its portfolio of anti-CD20 monoclonal antibodies drugs. As a result of this acquisition, the company acquired a 35% shares responsible for the growth of global anti-CD20 monoclonal antibodies market. 

Some of the players of global anti-CD20 monoclonal antibodies market are mentioned below:

  • Pfizer Inc
  • Hoffmann-La Roche Ltd.
  • Celltrion Inc.
  • Novartis AG
  • Amgen Inc. 

Global Anti-CD20 Monoclonal Antibodies Market: Key Drivers

Precision targeting of anti-CD20 mABs 

Anti-CD20 mABs are extensively effective as target therapies in treating cancer indications. These drugs target CD20 antigen on the cancer cells which is not possible in traditional therapies. Increasing research and developments in this field and various affirmative clinical trials are expected to boost the growth of global anti-CD20 monoclonal antibodies (mABs) market. 

Technological Developments in Healthcare Sectors 

Players in global anti-CD20 monoclonal antibodies (mABs) market are acquiring major share of the market based on the technological developments in various healthcare sectors. For instance, developments in pharmaceutical sector in improving the efficacy of the drugs and development of bispecific antibodies are some of the major factors that are influencing the growth of global anti-CD20 monoclonal antibodies (mABs) market in the forecast period of 2018 to 2028. 

Global Anti-CD20 Monoclonal Antibodies (Mabs) Market: Regional Analysis 

North America is expected to resister the maximum potential for the players of global anti-CD20 monoclonal antibodies market. The dominance of the region is expected to be the result of rising provenances of hematological malignancies such as NHL and recent approval of various late-stage pipeline drugs in countries like U.S. Moreover, the presence of various prominent players of global anti-CD20 monoclonal antibodies market in the region is further expected to boost the growth of North America in the anti-CD20 monoclonal antibodies market. 

The global anti-CD20 monoclonal antibodies market is segmented on the basis of:

  • Product 
    • Oncology
    • Neurology
    • Immunology

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?